Q1 FY2026 Earnings
Financial report interval: 2025.12.31 - 2026.03.31
Overview: Zenas Biopharma(ZBIO) the Revenue is 0 (-100%), Meet estimate;the EBIT is -77.35 M (-107.2%), Beat estimate;the EPS is -1.46 (-82.5%), Beat estimate.
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
0.00B100.00%
0.00B100.00%
0.00B0.00%
EBITExceed expectations
-0.08B107.21%
-0.09B144.87%
+0.01B37.66%
EPSExceed expectations
-1.4682.50%
-1.682110.25%
+0.222027.75%
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf